Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin in the Elderly
NCT02874924Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Jun 2016
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sirolimus in aging (3 arms), sponsored by UT Health San Antonio. Primary endpoint: Immunological Responses at 8 weeks. Started Jun 2016; status: completed.
02
Drugs
sirolimus
03
Conditions
aging
Beyond the preview
Go deeper on NCT02874924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874924.